Srx Health Solutions Inc's Business Segments

SRx Health Solutions Inc., through its subsidiary Better Choice Company, Inc., operates in the pet health and wellness sector under the Halo brand. The company offers over 100 premium and super-premium pet products, including kibble, canned food, freeze-dried raw food, treats, and supplements for dogs and cats. These products are distributed via e-commerce platforms such as Amazon and Chewy, select retail partners, and international distributors. In June 2024, the company exited direct-to-consumer sales on halopets.com. The Halo brand uses natural, sustainably sourced ingredients, including cage-free poultry, pasture-raised beef, and wild-caught fish, with manufacturing conducted in the United States by co-manufacturers Alphia, Simmons Pet Food, BrightPet Nutrition Group, and Carnivore Meat Company. SRx Health Solutions’ legacy specialty pharmaceuticals and healthcare services operations are classified as discontinued following bankruptcy and no longer generate significant revenue. For the fiscal year ended September 30, 2025, continuing operations generated approximately $6.5 million in net sales, primarily through e-commerce channels. Marketing efforts emphasize digital strategies and retailer partnerships, reflecting a shift from brick-and-mortar to a digital-first approach.

The registrant's reportable business segments included Canadian pharmacy and healthcare services through SRx Canada, and premium pet health and nutrition products sold through its subsidiary Halo, Purely for Pets, Inc. The Company discontinued its Canadian pharmacy and healthcare services operations conducted through SRx Canada during the year ended September 30, 2025; this segment is now classified as a discontinued operation. Following this discontinuation, the Company's continuing operations consist solely of its premium pet health and nutrition products segment operated through Halo, Purely for Pets, Inc. The Company completed a Spin-Out Distribution of shares of Halo Spin-Out SPV Inc., which held a 17% interest in Halo, to its stockholders; this did not result in a substantive change in ownership of Halo. Subsequently, the Company acquired the 17% interest in Halo previously held by Halo Spin-Out SPV, resulting in 100% ownership of Halo. This transaction was accounted for as an equity transaction with no change in controlling interest. The discontinued SRx healthcare business initiated restructuring proceedings under the Companies’ Creditors Arrangement Act in Canada, which does not affect the continuing pet food and pet wellness operations.